The impact of patient-reported outcome measures in clinical practice for pain: a systematic review

Abstract

PurposePatient-reported outcome measures (PROMs) have increasingly been incorporated into clinical practice. Research suggests that PROMs could be viewed as active components of complex interventions and may affect the process and outcome of care. This systematic review examines PROMs in the context of treatment for non-malignant pain.MethodsAn electronic search on: MEDLINE, EMBASE, PsycINFO, PsycARTICLES, Cochrane Library and Web of Science identified relevant papers (February 2015). The inclusion criteria were: focused on implementing PROMs into clinical practice, adults, and primary data studies. Critical interpretive synthesis was used to synthesise qualitative and quantitative findings into a theoretical argument.ResultsThirteen eligible studies were identified. Synthesis suggested that PROMs may be included in the initial consultation to assess patients and for shared decision-making regarding patient care. During the course of treatment, PROMs can be used to track progress, evaluate treatment, and change the course of care; using PROMs may also influence the therapeutic relationship. Post-treatment, using PROMs might directly influence other outcomes such as pain and patient satisfaction. However, although studies have investigated these areas, evidence is weak and inconclusive.ConclusionDue to the poor quality, lack of generalisability and heterogeneity of these studies, it is not possible to provide a comprehensive understanding of how PROMs may impact clinical treatment of non-malignant pain. The literature suggests that PROMs enable pain assessment, decision-making, the therapeutic relationship, evaluation of treatment and may influence outcomes. Further research is needed to provide better evidence as to whether PROMs do indeed have any effects on these domains.

Validation of the IPOS-Renal Symptom Survey in Advanced Kidney Disease: A Cross-sectional Study

“…Unlike traditional biophysical measures, PROMs such as the IPOS-renal allow the clinician to capture the patient's subjective illnesserelated concerns. 35 Validation of the psychometric properties of such an outcome measure is valuable to clinicians, researchers, and health administrators. The paucity of validation studies specifically involving the IPOS-renal could be considered a disadvantage, and our study sought to rectify this.…”

Planning for patient-reported outcome implementation: Development of decision tools and practical experience across four clinics

“…In applying our planning tools, we identified numerous challenges shared with prior studies, such as selecting just the right measure(s), engaging patients and physicians to obtain buy-in, and effectively using PRO results [25][26][27]. Also, concordant with the literature, we observed the importance of approaching PROs from an institutional perspective, identifying committed clinical leaders and teams, selecting appropriate instruments, taking action on concerning scores, and evaluating PRO use [28,29].…”

The Value of Patient-Reported Outcome (PRO) Data in Digital Healthcare: Using the How-R-you App as a PRO Instrument

“…Patients-especially with chronic diseases-need information in order to help themselves and self-manage their medical conditions. In many instances, both parties have incomplete information about patients' health and how their disease progresses [8]. In the case of patients with chronic diseases who need long-term healthcare, being able to continually monitor the patients and follow any developments is important from the perspective of doctors.…”